Chemistry: analytical and immunological testing – Optical result
Patent
1991-05-08
1993-06-29
Housel, James C.
Chemistry: analytical and immunological testing
Optical result
422 8209, 435 13, G01N 2100, G01N 2175
Patent
active
052234371
ABSTRACT:
An endpoint assay for measuring fibrinogen utilizing strong thrombin and weak plasma. In a preferred embodiment the assay is based on the direct conversion of a normalized signal from a sensor to fibrinogen concentration.
REFERENCES:
patent: 3658480 (1972-04-01), Kane et al.
patent: 3833864 (1974-09-01), Kiess et al.
patent: 3861877 (1975-01-01), Matharani et al.
patent: 3989382 (1976-11-01), Kent et al.
patent: 4659550 (1987-04-01), Schildknecht
patent: 4720787 (1988-01-01), Lipscomb
Brown, Hematology:, Principles and Procedures, Third Edition, 1982 by Lea & Febiger, Pa., pp. 15-16.
Henry et al., Clinical Chemistry, Principles and Technics, Bio-Science Laboratory, Second Edition, 1974 by Harper and Row, N.Y., pp. 453-455-460.
Callahan Janet B.
Hoffman Julie F.
Swope C. Hermas
Akzo N.V.
Bhat N.
Housel James C.
LandOfFree
Direct fibrinogen assay does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Direct fibrinogen assay, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Direct fibrinogen assay will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1754867